---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-27T10:39:14.978247'
end_time: '2025-12-27T10:45:13.630313'
duration_seconds: 358.65
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: KCTD18
  gene_symbol: KCTD18
  uniprot_accession: Q6PI47
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD18;'
  gene_info: Name=KCTD18;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: KCTD18_C. (IPR045704); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB.
    (IPR003131); BTB_2 (PF02214); KCTD18_C (PF19321)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 10
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q6PI47
- **Protein Description:** RecName: Full=BTB/POZ domain-containing protein KCTD18;
- **Gene Information:** Name=KCTD18;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** KCTD18_C. (IPR045704); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214); KCTD18_C (PF19321)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "KCTD18" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'KCTD18' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **KCTD18** (gene ID: KCTD18, UniProt: Q6PI47) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q6PI47
- **Protein Description:** RecName: Full=BTB/POZ domain-containing protein KCTD18;
- **Gene Information:** Name=KCTD18;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** KCTD18_C. (IPR045704); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214); KCTD18_C (PF19321)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "KCTD18" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'KCTD18' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **KCTD18** (gene ID: KCTD18, UniProt: Q6PI47) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan overview: We verified the target identity and domains (Objective 1), searched for recent family-level and KCTD18-specific sources prioritizing 2023–2024 (Objective 2), gathered and synthesized evidence on function, interactions, structural predictions, and localization (Objective 3), and prepared a concise artifact summarizing KCTD18-specific facts and caveats (Objective 5). Direct experimental literature on human KCTD18 remains sparse; therefore, we report confirmed and predicted properties with clear attribution and limitations.

| Aspect | Finding for KCTD18 | Evidence type (experiment/model/inference/family-level) | Source (short citation with year) | URL/DOI | Notes |
|---|---|---|---|---|---|
| Identity | Homo sapiens KCTD18; UniProt accession Q6PI47 (human) | Database / family-level corroboration | Balasco et al., 2024 (balasco2024acomprehensiveanalysis pages 1-2) | https://doi.org/10.3390/ijms25031881 | Matches user-provided UniProt identity and family assignment |
| Domains | Contains N-terminal BTB/POZ (T1-type_BTB) and a KCTD18_C C-terminal region | Domain annotation / family-level inference | Balasco et al., 2024 (balasco2024acomprehensiveanalysis pages 1-2) | https://doi.org/10.3390/ijms25031881 | Domain architecture aligns with UniProt-supplied domains |
| Predicted Cul3 interaction | AlphaFold2-based models predict a stable 1:1 BTB–Cul3 interaction for the KCTD18 BTB fragment | Structural model / prediction | Balasco et al., 2024 (balasco2024acomprehensiveanalysis pages 2-4) | https://doi.org/10.3390/ijms25031881 | Prediction only; no experimental validation for full-length KCTD18 reported in sources |
| Oligomeric state | KCTD18 predicted to be monomeric (family shows diversity; many KCTDs form pentamers) | Model/inference and family-level evidence | Balasco et al., 2024 (balasco2024acomprehensiveanalysis pages 8-9), Ramdass, 2025 (ramdass2025structuralmechanismsofa pages 22-31) | https://doi.org/10.3390/ijms25031881 (Balasco) | Family-level data show pentameric assemblies (e.g., KCTD5); KCTD18 may be an outlier (monomeric) per AF prediction |
| Substrates | No experimentally validated substrates reported for KCTD18 to date | Absence of experimental evidence / inference | Balasco et al., 2024 (balasco2024acomprehensiveanalysis pages 18-18), Ramdass, 2025 (ramdass2025structuralmechanismsofa pages 22-31) | https://doi.org/10.3390/ijms25031881 | Several other KCTDs have validated substrates (e.g., KCTD5, KCTD11), but none identified for KCTD18 in these sources |
| Cellular localization | Not established experimentally for KCTD18 in the gathered literature | Lack of direct experimental data / family-level inference | Reyes, 2016 (reyes2016thesubcellularlocalization pages 15-19) | (no DOI available in source) | Family members localize variably (cytosol, nucleus, mitochondria); KCTD18 localization remains to be determined |
| Family functional paradigm | KCTDs often act as substrate adaptors for CRL3 (BTB recruits Cul3; CTD binds substrates). Example: KCTD5–Cul3 ubiquitinates Gβγ (2023 cryo-EM + functional work) | Experimental (cryo-EM + functional) and family-level generalization | Jiang et al., 2023 (cited in Balasco et al., 2024) (balasco2024acomprehensiveanalysis pages 18-18) | Jiang et al. DOI: 10.1126/sciadv.adg8369 (balasco2024acomprehensiveanalysis pages 18-18) | Demonstrates mechanism for family (pentameric assembly and substrate ubiquitination); provides functional model applicable to other KCTDs |
| CRL3 / KCTD general properties | BTB domain mediates Cul3 recruitment; C-terminal regions (CTDs) determine substrate specificity; KCTDs form CRL3 adaptor complexes | Family-level experimental and modeling evidence | Balasco et al., 2024 (balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 16-18) | https://doi.org/10.3390/ijms25031881 | Repeatedly observed across multiple KCTD members; supports hypothesis that KCTD18 could function as a CRL3 adaptor if Cul3 binding is validated |
| Structural confidence caveat | Some AF/structure models for KCTD18 (and KCTD19) were judged low-confidence/unreliable in a family-wide survey; experimental structures needed | Model evaluation / caveat | Ramdass, 2025 (ramdass2025structuralmechanismsofa pages 22-31), Balasco et al., 2024 (balasco2024acomprehensiveanalysis pages 2-4) | (Ramdass 2025: no DOI available in source), https://doi.org/10.3390/ijms25031881 (Balasco) | Emphasizes need for biochemical or cryo-EM/ crystallography validation for KCTD18-specific claims |


*Table: Concise summary of KCTD18 identity, domains, predicted interactions, oligomeric state, localization status, family paradigm, and confidence caveats with evidence type and sources (2023–2025), useful as a quick reference for further experimental planning.*

Executive summary
KCTD18 (UniProt Q6PI47) is a human BTB/POZ domain-containing KCTD-family protein. Recent structural-prediction work (2024) supports a BTB-mediated interaction with CUL3, suggesting a role as a CRL3 substrate adaptor. However, there are no experimentally confirmed substrates, oligomeric state, or cellular localization data specific to human KCTD18 as of the latest accessible literature. The broader KCTD family provides mechanistic context: BTB domains recruit CUL3 while variable C-terminal domains confer substrate recognition; several KCTDs form pentameric adaptors and mediate substrate ubiquitination (e.g., KCTD5 targeting Gβγ in 2023 structural work), informing plausible functions for KCTD18 that require direct validation (balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 2-4, balasco2024acomprehensiveanalysis pages 18-18, ramdass2025structuralmechanismsofa pages 22-31).

1) Key concepts and definitions
- Identity and domains: KCTD18 is a Homo sapiens protein of the KCTD family defined by an N-terminal BTB/POZ (T1-type) domain and a distinct KCTD18_C C-terminal region. The BTB domain underlies oligomerization and interactions, particularly with CUL3; CTDs generally mediate substrate binding (balasco2024acomprehensiveanalysis pages 1-2, ramdass2025structuralmechanismsofa pages 22-31). URL: https://doi.org/10.3390/ijms25031881 (published Feb 2024).
- Functional paradigm (family): Many KCTDs serve as substrate adaptors in CRL3 E3 ubiquitin ligases, where the BTB contacts CUL3 and the CTD binds substrates for ubiquitination and proteasomal degradation. Oligomeric assemblies vary across the family, with several members forming pentamers (balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 16-18, ramdass2025structuralmechanismsofa pages 22-31). URL: https://doi.org/10.3390/ijms25031881 (Feb 2024).

2) Recent developments and latest research (2023–2024 prioritized)
- Predicted KCTD18–CUL3 recognition: A 2024 structural-prediction analysis across all KCTDs reports reliable models only for KCTDs known to bind CUL3; within this, the KCTD18 BTB fragment is predicted to form a stable 1:1 complex with CUL3, suggesting KCTD18 is a CUL3 interactor. The same study notes KCTD18 is phylogenetically close to cluster 4 and is presumptively monomeric in their models, though this requires experimental confirmation (balasco2024acomprehensiveanalysis pages 2-4, balasco2024acomprehensiveanalysis pages 8-9). URL: https://doi.org/10.3390/ijms25031881 (Feb 2024).
- Family-level structural and mechanistic insights: High-resolution 2023 work on KCTD5/CRL3 defined a pentameric adaptor that binds and ubiquitinates five copies of Gβγ, providing a detailed mechanism for KCTD-mediated substrate recognition and coordinated ubiquitin transfer. This study underscores diversity in KCTD oligomeric states and highlights KCTDs as emerging regulators of GPCR signaling (Jiang 2023; referenced within 2024 review) (balasco2024acomprehensiveanalysis pages 18-18). URL: https://doi.org/10.1126/sciadv.adg8369 (Jul 2023).
- Model-confidence caveat for KCTD18: A 2025 family-focused review cautions that AlphaFold models for KCTD18 (and KCTD19) were judged too unreliable for detailed interpretation, emphasizing the need for experimental validation specific to KCTD18 (ramdass2025structuralmechanismsofa pages 22-31). (No URL available in the provided excerpt.)

3) Current applications and real-world implementations
- Application of family paradigms to infer KCTD18 function: Based on family precedence, if KCTD18 engages CUL3 via its BTB, it could function as a CRL3 adaptor targeting specific substrates via its CTD. Real-world mechanistic templates include KCTD5-mediated ubiquitination of Gβγ (impacting GPCR/cAMP signaling). These implementations guide experimental design for KCTD18 (e.g., testing CUL3 binding, oligomerization, and substrate capture) (balasco2024acomprehensiveanalysis pages 18-18, balasco2024acomprehensiveanalysis pages 1-2).
- Drug-targeting strategies (family-level): Prior work has explored disrupting the CUL3–BTB interface and peptide-based modulation of KCTD–CUL3 recognition; while not KCTD18-specific, these approaches suggest potential routes to modulate KCTD18–CRL3 activity if its interaction is validated (balasco2024acomprehensiveanalysis pages 18-18). URL: https://doi.org/10.3390/ijms25031881 (Feb 2024).

4) Expert opinions and analysis
- Structural recognition consensus: The 2024 comprehensive analysis argues that modern structure prediction discriminates CUL3-binding vs non-binding KCTDs, reporting consistent recognition modes for most CUL3-binding KCTDs. The paper groups KCTDs into clusters and describes KCTD18 as an isolated protein near cluster 4, likely monomeric but CUL3-binding by BTB predictions, emphasizing structural variability and the need for empirical validation (balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 8-9). URL: https://doi.org/10.3390/ijms25031881 (Feb 2024).
- Family-wide mechanism: Reviews and comparative analyses concur that KCTD BTB domains recruit CUL3 and that CTDs determine substrates, with diverse oligomers often forming pentamers. This consensus frames KCTD18 as a probable CRL3 adaptor candidate pending biochemical confirmation (balasco2024acomprehensiveanalysis pages 16-18, ramdass2025structuralmechanismsofa pages 22-31). URL: https://doi.org/10.3390/ijms25031881 (Feb 2024).

5) Relevant statistics and data from recent studies
- CUL3-binding prevalence and modeling: The 2024 analysis reports that reliable KCTD–CUL3 models were produced only for KCTDs known to interact with CUL3 (15 members), and KCTD18’s BTB fragment modeled as a 1:1 complex with CUL3, consistent with a CUL3-adaptor role (balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 2-4). URL: https://doi.org/10.3390/ijms25031881 (Feb 2024).
- Oligomeric diversity (family): Structural work indicates multiple oligomeric states across KCTDs, with several adopting pentameric assemblies (e.g., KCTD5), while others may behave as monomers or dimers; the BTB fold is homologous to the Kv channel T1 tetramerization domain, suggesting quaternary flexibility (ramdass2025structuralmechanismsofa pages 22-31, balasco2024acomprehensiveanalysis pages 1-2). URL: https://doi.org/10.3390/ijms25031881 (Feb 2024).

Functional annotation for human KCTD18 (Q6PI47)
- Molecular function: Predicted CUL3 adaptor activity mediated by an N-terminal BTB domain, by analogy with other KCTDs and supported by an AlphaFold-predicted KCTD18BTB–CUL3 1:1 complex. No direct enzymatic activity or confirmed substrates for KCTD18 have been reported in the retrieved literature (balasco2024acomprehensiveanalysis pages 2-4, balasco2024acomprehensiveanalysis pages 1-2, ramdass2025structuralmechanismsofa pages 22-31).
- Interactions: Predicted BTB–CUL3 recognition (1:1) for KCTD18; numerous KCTDs use BTB to bind CUL3 while CTDs bind substrates. Specific KCTD18 interactors and substrates remain unidentified (balasco2024acomprehensiveanalysis pages 2-4, balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 16-18).
- Oligomeric state: The 2024 modeling suggests KCTD18 is presumptively monomeric, but KCTD family precedent includes pentamers and other oligomers; thus, KCTD18’s oligomeric state is currently unverified and should be established experimentally (balasco2024acomprehensiveanalysis pages 8-9, ramdass2025structuralmechanismsofa pages 22-31).
- Substrate specificity: Unknown for KCTD18; by family analogy, the CTD is expected to confer substrate recognition if KCTD18 functions as a CRL3 adaptor (balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 16-18).
- Cellular localization: Not established experimentally for KCTD18. KCTD family members localize to cytosol, nucleus, and, in some cases, associate with organelles; KCTD13 mitochondrial co-localization is an example of family diversity but should not be generalized to KCTD18 (reyes2016thesubcellularlocalization pages 15-19).

Limitations and confidence
- The gene symbol KCTD18 is unambiguous for human and matches UniProt Q6PI47 and BTB/KCTD family annotations provided. Direct KCTD18-specific experimental evidence is limited; most claims are supported by family-level data and a 2024 structural-prediction study. A 2025 review flags low-confidence models for KCTD18, underscoring the need for experimental validation of CUL3 binding, oligomerization, localization, and substrates (ramdass2025structuralmechanismsofa pages 22-31, balasco2024acomprehensiveanalysis pages 2-4, balasco2024acomprehensiveanalysis pages 1-2).

Actionable experimental suggestions (informed by family mechanisms)
- Validate KCTD18–CUL3 interaction via co-immunoprecipitation and in vitro binding using BTB truncations; assess the predicted 1:1 binding mode (balasco2024acomprehensiveanalysis pages 2-4, balasco2024acomprehensiveanalysis pages 1-2).
- Determine oligomeric state by SEC-MALS and native MS; test for monomeric versus oligomeric BTB assemblies (ramdass2025structuralmechanismsofa pages 22-31, balasco2024acomprehensiveanalysis pages 1-2).
- Map cellular localization using tagged constructs and fractionation; compare among cytosolic, nuclear, and organelle-associated pools (reyes2016thesubcellularlocalization pages 15-19).
- Identify substrates by proximity labeling (BioID/APEX) and proteomics in KCTD18 gain- and loss-of-function contexts; test CRL3 dependency via CUL3/RBX1 perturbation (balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 16-18).

References with URLs and dates
- Balasco N, Esposito L, Smaldone G, Salvatore M, Vitagliano L. A comprehensive analysis of the structural recognition between KCTD proteins and Cullin 3. International Journal of Molecular Sciences. Published Feb 2024. URL: https://doi.org/10.3390/ijms25031881 (balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 2-4, balasco2024acomprehensiveanalysis pages 18-18, balasco2024acomprehensiveanalysis pages 16-18, balasco2024acomprehensiveanalysis pages 8-9).
- Jiang W, Wang W, Kong Y, Zheng S. Structural basis for the ubiquitination of G protein βγ subunits by KCTD5/Cullin3 E3 ligase. Science Advances. Published Jul 5, 2023. URL: https://doi.org/10.1126/sciadv.adg8369 (balasco2024acomprehensiveanalysis pages 18-18).
- Ramdass AE. Structural mechanisms of multimeric BTB E3 ligases and interactors. 2025. (Review cited for family-level mechanisms and model confidence notes for KCTD18; no URL provided in the excerpt) (ramdass2025structuralmechanismsofa pages 22-31).
- Reyes AAA. The Subcellular Localization of the Uncharacterized Human Disease-Associated Protein KCTD13. 2016. (Family context for localization diversity; no URL provided in the excerpt) (reyes2016thesubcellularlocalization pages 15-19).

Conclusion
Human KCTD18 (Q6PI47) is a BTB/POZ-containing KCTD-family protein with predicted BTB–CUL3 recognition consistent with a CRL3 adaptor role. Nonetheless, its oligomeric state, cellular localization, and substrates have not been experimentally defined. Recent 2023–2024 advances in KCTD structural biology support mechanistic hypotheses for KCTD18 but also highlight the necessity of targeted biochemical and structural validation for this specific protein (balasco2024acomprehensiveanalysis pages 1-2, balasco2024acomprehensiveanalysis pages 2-4, balasco2024acomprehensiveanalysis pages 18-18, ramdass2025structuralmechanismsofa pages 22-31).

References

1. (balasco2024acomprehensiveanalysis pages 1-2): Nicole Balasco, Luciana Esposito, Giovanni Smaldone, Marco Salvatore, and Luigi Vitagliano. A comprehensive analysis of the structural recognition between kctd proteins and cullin 3. International Journal of Molecular Sciences, 25:1881, Feb 2024. URL: https://doi.org/10.3390/ijms25031881, doi:10.3390/ijms25031881. This article has 12 citations and is from a poor quality or predatory journal.

2. (balasco2024acomprehensiveanalysis pages 2-4): Nicole Balasco, Luciana Esposito, Giovanni Smaldone, Marco Salvatore, and Luigi Vitagliano. A comprehensive analysis of the structural recognition between kctd proteins and cullin 3. International Journal of Molecular Sciences, 25:1881, Feb 2024. URL: https://doi.org/10.3390/ijms25031881, doi:10.3390/ijms25031881. This article has 12 citations and is from a poor quality or predatory journal.

3. (balasco2024acomprehensiveanalysis pages 8-9): Nicole Balasco, Luciana Esposito, Giovanni Smaldone, Marco Salvatore, and Luigi Vitagliano. A comprehensive analysis of the structural recognition between kctd proteins and cullin 3. International Journal of Molecular Sciences, 25:1881, Feb 2024. URL: https://doi.org/10.3390/ijms25031881, doi:10.3390/ijms25031881. This article has 12 citations and is from a poor quality or predatory journal.

4. (ramdass2025structuralmechanismsofa pages 22-31): AE Ramdass. Structural mechanisms of multimeric btb e3 ligases and interactors. Unknown journal, 2025.

5. (balasco2024acomprehensiveanalysis pages 18-18): Nicole Balasco, Luciana Esposito, Giovanni Smaldone, Marco Salvatore, and Luigi Vitagliano. A comprehensive analysis of the structural recognition between kctd proteins and cullin 3. International Journal of Molecular Sciences, 25:1881, Feb 2024. URL: https://doi.org/10.3390/ijms25031881, doi:10.3390/ijms25031881. This article has 12 citations and is from a poor quality or predatory journal.

6. (reyes2016thesubcellularlocalization pages 15-19): AAA Reyes. The subcellular localization of the uncharacterized human disease-associated protein potassium channel tetramerization domain 13 (kctd13). Unknown journal, 2016.

7. (balasco2024acomprehensiveanalysis pages 16-18): Nicole Balasco, Luciana Esposito, Giovanni Smaldone, Marco Salvatore, and Luigi Vitagliano. A comprehensive analysis of the structural recognition between kctd proteins and cullin 3. International Journal of Molecular Sciences, 25:1881, Feb 2024. URL: https://doi.org/10.3390/ijms25031881, doi:10.3390/ijms25031881. This article has 12 citations and is from a poor quality or predatory journal.

## Citations

1. balasco2024acomprehensiveanalysis pages 1-2
2. balasco2024acomprehensiveanalysis pages 2-4
3. balasco2024acomprehensiveanalysis pages 8-9
4. ramdass2025structuralmechanismsofa pages 22-31
5. balasco2024acomprehensiveanalysis pages 18-18
6. reyes2016thesubcellularlocalization pages 15-19
7. balasco2024acomprehensiveanalysis pages 16-18
8. https://doi.org/10.3390/ijms25031881
9. https://doi.org/10.1126/sciadv.adg8369
10. https://doi.org/10.3390/ijms25031881,